Neuron-specific non-classical release of prothymosin alpha: A novel neuroprotective damage-associated molecular patterns

Journal of Neurochemistry

Volumn 123, Issue 2, 2012, Pages 262-275

  Halder, Sebok Kumar ^a   Matsunaga, Hayato ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

apoptosis; cerebral ischemia; necrosis; neuroprotective DAMPs; non classical release; S100A13

Indexed keywords

AMLEXANOX; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN S100A13; PROTHYMOSIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG SAFETY; HIPPOCAMPUS; IMMUNOREACTIVITY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; STRESS; UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN; BRAIN ISCHEMIA; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN PRECURSORS; THYMOSIN;

EID: 84867074163     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07897.x     Document Type: Article

References (61)

1. Baxevanis C. N., Thanos D., Reclos G. J., Anastasopoulos E., Tsokos G. C., Papamatheakis J., and, Papamichail M., (1992) Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. J. Immunol. 148, 1979-1984.
2. Bianchi M. E., (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
3. Chen G. Y., and, Nunez G., (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-37.
4. Chen Y., and, Swanson R. A., (2003) Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23, 137-149.
5. Danton G. H., and, Dietrich W. D., (2003) Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62, 127-136.
6. Diaz-Jullien C., Perez-Estevez A., Covelo G., and, Freire M., (1996) Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. Biochim. Biophys. Acta 1296, 219-227.
7. Duran-Vilaregut J., Del Valle J., Manich G., Junyent F., Camins A., Pallas M., Pelegri C., and, Vilaplana J., (2010) Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes. Neurochem. Int. 56, 443-450.
8. Egashira N., Hayakawa K., Mishima K., Kimura H., Iwasaki K., and, Fujiwara M., (2004) Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci. Lett. 363, 58-61.
9. Enkemann S. A., Ward R. D., and, Berger S. L., (2000) Mobility within the nucleus and neighboring cytosol is a key feature of prothymosin-alpha. J. Histochem. Cytochem. 48, 1341-1355.
10. Evatafieva A. G., Belov G. A., Rubtsov Y. P., et al,. (2003) Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha. Exp. Cell Res. 284, 211-223.
11. Faraco G., Fossati S., Bianchi M. E., Patrone M., Pedrazzi M., Sparatore B., Moroni F., and, Chiarugi A., (2007) High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J. Neurochem. 103, 590-603.
12. Faustino J. V., Wang X., Johnson C. E., Klibanov A., Derugin N., Wendland M. F., and, Vexler Z. S., (2011) Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J. Neurosci. 31, 12992-13001.
13. Foell D., Wittkowski H., and, Roth J., (2007) Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3, 382-390.
14. Fujita R., and, Ueda H., (2007) Prothymosin-alpha1 prevents necrosis and apoptosis following stroke. Cell Death Differ. 14, 1839-1842.
15. Fujita R., Ueda M., Fujiwara K., and, Ueda H., (2009) Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ. 16, 349-358.
16. Garbin F., Eckert K., Immenschuh P., Kreuser E. D., and, Maurer H. R., (1997) Prothymosin alpha 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int. J. Immunopharmacol. 19, 323-332.
17. Gardella S., Andrei C., Ferrera D., Lotti L. V., Torrisi M. R., Bianchi M. E., and, Rubartelli A., (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995-1001.
18. George E. M., and, Brown D. T., (2010) Prothymosin alpha is a component of a linker histone chaperone. FEBS Lett. 584, 2833-2836.
19. Giffard R. G., and, Swanson R. A., (2005) Ischemia-induced programmed cell death in astrocytes. Glia 50, 299-306.
20. Gomez-Marquez J., (2007) Function of prothymosin alpha in chromatin decondensation and expression of thymosin beta-4 linked to angiogenesis and synaptic plasticity. Ann. N. Y. Acad. Sci. 1112, 201-209.
21. Gomez-Marquez J., and, Rodriguez P., (1998) Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem. J. 333, 1-3.
22. Halder S. K., and, Ueda H., (2012) Regional distribution and cell type-specific subcellular localization of prothymosin alpha in brain. Cell. Mol. Neurobiol. 32, 59-66.
23. Jiang X., Kim H. E., Shu H., et al,. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299, 223-226.
24. Karapetian R. N., Evstafieva A. G., Abaeva I. S., et al,. (2005) Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell. Biol. 25, 1089-1099.
25. Karetsou Z., Kretsovali A., Murphy C., Tsolas O., and, Papamarcaki T., (2002) Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep. 3, 361-366.
26. Kono H., and, Rock K. L., (2008) How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-288.
27. Lambertsen K. L., Clausen B. H., Babcock A. A., et al,. (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29, 1319-1330.
28. Letsas K. P., and, Frangou-Lazaridis M., (2006) Surfing on prothymosin alpha proliferation and anti-apoptotic properties. Neoplasma 53, 92-96.
29. Liu K., Mori S., Takahashi H. K., et al,. (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21, 3904-3916.
30. Lotze M. T., and, Tracey K. J., (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342.
31. Martini P. G., Delage-Mourroux R., Kraichely D. M., and, Katzenellenbogen B. S., (2000) Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell. Biol. 20, 6224-6232.
32. Matsumoto M., Inoue M., Hald A., Xie W., and, Ueda H., (2006) Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J. Pharmacol. Exp. Ther. 318, 735-740.
33. Matsunaga H., and, Ueda H., (2010) Stress-induced non-vesicular release of prothymosin-alpha initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage. Cell Death Differ. 17, 1760-1772.
34. Mosoian A., Teixeira A., High A. A., Christian R. E., Hunt D. F., Shabanowitz J., Liu X., and, Klotman M., (2006) Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J. Virol. 80, 9200-9206.
35. Mosoian A., Teixeira A., Burns C. S., Sander L. E., Gusella G. L., He C., Blander J. M., Klotman P., and, Klotman M. E., (2010) Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc. Natl Acad. Sci. USA 107, 10178-10183.
36. Muhammad S., Barakat W., Stoyanov S., et al,. (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 28, 12023-12031.
37. Nickel W., (2005) Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614.
38. Nickel W., and, Rabouille C., (2009) Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148-155.
39. Niizuma K., Yoshioka H., Chen H., Kim G. S., Jung J. E., Katsu M., Okami N., and, Chan P. H., (2010) Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim. Biophys. Acta 1802, 92-99.
40. Oshiro S., Kawamura K., Zhang C., Sone T., Morioka M. S., Kobayashi S., and, Nakajima S., (2008) Microglia and astroglia prevent oxidative stress-induced neuronal cell death: Implications for aceruloplasminemia. Biochim. Biophys. Acta 1782, 109-117.
41. Pineiro A., Cordero O. J., and, Nogueira M., (2000) Fifteen years of prothymosin alpha: contradictory past and new horizons. Peptides 21, 1433-1446.
42. Pisetsky D. S., (2011) Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes. Swiss Med. Wkly 141, 1-7.
43. Prudovsky I., Tarantini F., Landriscina M., Neivandt D., Soldi R., Kirov A., Small D., Kathir K. M., Rajalingam D., and, Kumar T. K., (2008) Secretion without Golgi. J. Cell. Biochem. 103, 1327-1343.
44. Qiu J., Nishimura M., Wang Y., Sims J. R., Qiu S., Savitz S. I., Salomone S., and, Moskowitz M. A., (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927-938.
45. Rossi D. J., Brady D. J., and, Mohr C., (2007) Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10, 1377-1386.
46. Rubartelli A., and, Lotze M. T., (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28, 429-436.
47. Rubtsov Y. P., Zolotukhin A. S., Vorobjev I. A., Chichkova N. V., Pavlov N. A., Karger E. M., Evstafieva A. G., Felber B. K., and, Vartapetian A. B., (1997) Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal. FEBS Lett. 413, 135-141.
48. Scaffidi P., Misteli T., and, Bianchi M. E., (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195.
49. Schmidt E. P., and, Tuder R. M., (2010) Role of apoptosis in amplifying inflammatory responses in lung diseases. J. Cell Death 3, 41-53.
50. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., and, Coyle A. J., (2010) HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367-388.
51. Swanson R. A., Ying W., and, Kauppinen T. M., (2004) Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4, 193-205.
52. Trendelenburg G., and, Dirnagl U., (2005) Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 51, 307-320.
53. Ueda H., (2008) Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke. Naunyn Schmiedebergs Arch. Pharmacol. 377, 315-323.
54. Ueda H., (2009) Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage. Pharmacol. Ther. 123, 323-333.
55. Ueda H., and, Fujita R., (2004) Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27, 950-955.
56. Ueda H., Fujita R., Yoshida A., Matsunaga H., and, Ueda M., (2007) Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J. Cell Biol. 176, 853-862.
57. Ueda H., Matsunaga H., Uchida H., and, Ueda M., (2010) Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann. N. Y. Acad. Sci. 1194, 20-26.
58. Yang H., Hreggvidsdottir H. S., Palmblad K., et al,. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl Acad. Sci. USA 107, 11942-11947.
59. Zhang J., Takahashi H. K., Liu K., et al,. (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42, 1420-1428.
60. Zhao Y., and, Rampe D. A., (2010) Targeting astrocytes for stroke therapy. Neurotherapeutics 7, 439-451.
61. Zitvogel L., Kepp O., and, Kroemer G., (2010) Decoding cell death signals in inflammation and immunity. Cell 140, 798-804.